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Selected dietary (poly)phenols inhibit periodontal
pathogen growth and bioﬁlm formation
Muhammad Shahzad,a Emma Millhouse,b Shauna Culshaw,b Christine A. Edwards,a
Gordon Ramageb and Emilie Combet*a
Periodontitis (PD) is a chronic infectious disease mediated by bacteria in the oral cavity. (Poly)phenols
(PPs), ubiquitous in plant foods, possess antimicrobial activities and may be useful in the prevention and
management of periodontitis. The objective of this study was to test the antibacterial eﬀects of selected
PPs on periodontal pathogens, on both planktonic and bioﬁlm modes of growth. Selected PPs (n = 48)
were screened against Streptococcus mitis (S. mitis), Aggregatibacter actinomycetemcomitans (A. actino-
mycetemcomitans), Fusobacterium nucleatum (F. nucleatum) and Porphyromonas gingivalis (P. gingivalis).
The antibacterial potential of each compound was evaluated in terms of planktonic minimum inhibitory
concentration (PMIC) and planktonic minimum bactericidal concentration (PMBC) using standardized
broth microdilution assays. The most active PPs were further tested for their eﬀect on mono-species and
multi-species bioﬁlms using a colorimetric resazurin-based viability assay and scanning electron
microscopy. Of the 48 PPs tested, 43 showed eﬀective inhibition of planktonic growth of one or more
test strains, of which curcumin was the most potent (PMIC range = 7.8–62.5 μg mL−1), followed by pyro-
gallol (PMIC range = 2.4–2500 μg mL−1), pyrocatechol (MIC range = 4.9–312.5 μg mL−1) and quercetin
(PMIC range = 31.2–500 μg mL−1). At this concentration, adhesion of curcumin and quercetin to the sub-
strate also inhibited adhesion of S. mitis, and bioﬁlm formation and maturation. While both curcumin and
quercetin were able to alter architecture of mature multi-species bioﬁlms, only curcumin-treated bioﬁlms
displayed a signiﬁcantly reduced metabolic activity. Overall, PPs possess antibacterial activities against
periodontopathic bacteria in both planktonic and bioﬁlm modes of growth. Further cellular and in vivo
studies are necessary to conﬁrm their beneﬁcial activities and potential use in the prevention and or treat-
ment of periodontal diseases.
Introduction
Periodontitis (PD) is a common chronic disease triggered by
the bacterial biofilm of dental plaque, resulting in inflamma-
tory loss of tooth supporting tissues.1 It is a major public
health issue of significant economic impact, aﬀecting 10–15%
of the world adult population2 and is the most common cause
of tooth loss in adults.3 Moreover, a number of clinical and
animal studies have identified positive and independent
relationships between chronic periodontitis and other systemic
conditions, including diabetes, cardiovascular and respiratory
diseases.4–6
In humans, PD is commonly associated with a dental
plaque biofilm that accumulates on the tooth surfaces. It is
one of the most complex and diverse microbial ecosystems
within the human body, encompassing some 700 diﬀerent
reported bacterial species.7 However, initiation and causation
of periodontitis is associated with a few pathogenic species,
including P. gingivalis and P. intermedia, and A. actinomycetem-
comitans in aggressive periodontitis.8
Current management approaches include periodontal
surgery, scaling and root planning along with adjunctive anti-
biotic therapy.9 However, these treatment options not only
have limited eﬀectiveness in high risk populations and in
those with advanced periodontal disease,10 but can also be
associated with adverse side eﬀects and antibiotic resistance.11
Therefore, alternative therapeutic and preventive measures
which are safe, eﬀective and free of side eﬀects, are highly
desirable.12
In recent years, an increasing interest has been observed in
the use of natural compounds (of dietary origin) for the man-
agement of oral infectious diseases, including caries,13 oral
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candidosis14 and periodontitis.15 While plant-derived phyto-
chemicals, especially the (poly)phenols (PPs), have been
studied for their antioxidant and anti-inflammatory pro-
perties,16 the antimicrobial properties of PPs have received
limited exposure in the context of prevention and treatment of
PD.17 Nevertheless, several studies have reported the inhibitory
activities of certain PP extracts, including cranberries, lotus,
seaweed and perilla seeds against a range of planktonic perio-
dontal pathogens.18–21 Moreover, the antibacterial activity of
flavan-3-ol-rich green tea extracts has been reported against
planktonic S. mitis, P. gingivalis and F. nucleatum.22–25 Others
have quantified the antibacterial activity of specific PP mole-
cules (including gallic acid, naringin and quercetin) on plank-
tonic P. gingivalis and F. nucleatum.21,26–28 In addition, there
are reports that the antimicrobial potential of PPs depends on
their chemical structure.29,30 Given that periodontal pathogens
in dental plaque exist in the form of biofilm, there has been
very limited research investigating the eﬀect of PPs on biofilm
development and formation. Therefore, the aim of the present
study was to evaluate the potential of a panel of PPs in inhibit-
ing growth and biofilm formation of PD pathogens, with
emphasis on structure–function relationship, if any.
Materials and methods
Bacterial strains, media and culture conditions
The bacterial strains used in the study were S. mitis NCTC
12261, A. actinomycetemcomitans ATCC 43718, P. gingivalis
ATCC 33277 and F. nucleatum ATCC 10953. Prior to each experi-
ment, working stocks were prepared by plating bacterial cells
from frozen stocks (Microbank vials, Pro-Lab Diagnostics, Che-
shire, UK). S. mitis and A. actinomycetemcomitans were main-
tained on Columbia agar plates with 5% defibrinated horse
blood (E & O laboratories, UK; Ref DHB 100), then placed in a
5% CO2 incubator for 24 h at 37 °C. P. gingivalis and F. nuclea-
tum were inoculated on fastidious blood agar supplemented
with 5% defibrinated horse blood and incubated in an anaero-
bic chamber containing 85% N2, 10% CO2 and 5% H2 (Don
Whitley Scientific Limited, UK) at 37 °C for 72 h. Prior to each
experiment, the test strains were grown to stationary phase
using appropriate nutrient broth: tryptic soy broth (Sigma,
Poole, UK) supplemented with 0.8% glucose and 0.6% yeast
extract for S. mitis and A. actinomycetemcomitans, and Schae-
dler anaerobic broth (Oxoid, Cambridge, UK) for F. nucleatum
and P. gingivalis and respective growth conditions. Bacterial
cultures were washed by centrifugation at 3000 rpm for 5 min
in PBS and the cell count estimated using spectrophotometer,
and confirmed by plate counting (CFU mL−1).
(Poly)phenolic compounds
Forty eight purified (HPLC grade) PP compounds (Sigma
Aldrich, Poole, UK) were used in this study. Depending on
solubility, a fresh stock concentration of each PP was prepared
either in water or dimethyl sulfoxide (DMSO, Sigma Aldrich,
Poole, UK) and stored at −20 °C until required. Dilutions of
the stock were made in respective growth media for each
strain. The final concentration of DMSO was adjusted to less
than 3% (v/v), which was shown to have no discernible eﬀect
on the growth of test strains (data not shown). All solution pre-
paratory steps were carried out in a laminar flow hood (Micro-
flow, Hampshire, England, UK).
Planktonic susceptibility testing
The inhibitory potential of PPs (n = 48) against planktonic
growth of the test strains (n = 4) was assessed in terms of
planktonic minimum inhibitory concentration (PMIC) and
planktonic minimum bactericidal concentration (PMBC) using
broth microdilution technique following standard CLSI guide-
lines.31 Briefly, standardized (1 × 105 CFU mL−1) inoculums of
the test strain were prepared in appropriate nutrient broth.
The inoculum was loaded into 96-well, round bottom, poly-
styrene microtitre plates (Corning Incorporated, NY, USA) con-
taining serial double dilutions of each PP (within their soluble
range and triplicates). After incubation, the plates were visually
inspected for any visible growth. The maximum dilution of the
test compound that inhibited visible growth was recorded as
PMIC, and the PMBC was determined by inoculating from
those wells at concentrations ≥PMIC and assessing growth
thereafter on their respective agar plate. The first concen-
tration with no growth was recorded as the PMBC.
Manufacture of hydroxyapatite coated plates
The eﬀect of PPs on biofilm formation and maturation was
assessed using flat bottom, 96-well polystyrene microtitre
plates (Corning Incorporated, NY, USA), coated with hydroxy-
apatite (HA, Sigma Aldrich, Poole, UK; Product no 289396) by
modification of the method described by Schilling et al.32
Briefly, a uniform (10% w/v) HA suspension was prepared in
acetone. It was homogenized prior to transfer (60 μL) into each
well of the microtitre plate. The plates were maintained on an
orbital shaker set at 200 rpm and in 37 °C incubator for
15 min. After drying, loose HA powder was removed by tapping
the plate, which was then washed twice in PBS and dried over-
night at 37 °C. Before use, the plates were sterilized by soaking
in 70% ethanol for 10 min, washed, dried and placed in an
ultraviolet cabinet for 30 min.
Adsorption of (poly)phenols to the substrate HA
Adsorption aﬃnity of PPs was assessed following the method
of Shellis et al.,33 with slight modifications. Briefly, 1.5 mL
stock solutions (50 μg mL−1) of selected PPs (n = 10) were
added into Eppendorf tubes containing 200 mg of fresh HA
powder. Appropriate controls (PPs without HA) and blanks
(HA and water) were also included. PPs were allowed to adsorb
onto HA by incubating for 1 h at room temperature with
occasional inversion and protection from light. After incu-
bation, PP/HA suspensions were centrifuged at 5000 g for
5 min and the supernatants analysed for total phenol content
using the Folin–Ciocalteau method.34 The total amount of PPs
adsorbed per gram of HA (μg g−1 of HA) was determined by
measuring the diﬀerence in PP concentration between sample
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and control. All experiments were carried out on two diﬀerent
occasions using samples and controls in triplicate.
Eﬀect of selected (poly)phenols adsorption to HA on adhesion
of S. mitis
A viability assay based on reduction of resazurin by metaboli-
cally active cells35 was used to assess the eﬀect of PP adsorp-
tion on HA-coated plates (biofilm substrate), prior to adhesion
of S. mitis and biofilm formation. First, artificial saliva (AS)
was prepared by adding porcine stomach mucin (0.25% w/v),
sodium chloride (0.35 w/v), potassium chloride (0.02 w/v),
calcium chloride dihydrate (0.02 w/v), yeast extract (0.2 w/v),
Lab-Lemco powder; meat extract made from specially selected
raw materials to enhance bacterial growth in media (0.1 w/v;
Oxoid, Cambridge, UK; product code LP0029), proteose
peptone (0.5 w/v) into ddH2O (Sigma, Poole, UK).
36 This was
sterilised by autoclaving prior to addition of urea (0.05% v/v),
with a final pH of 7.4. Subsequently, AS containing PMIC con-
centration of selected PPs was added into each well of a HA-
coated 96 well plate. Plates were sealed with adhesive lids and
stored at 4 °C overnight to allow adsorption. The following day,
PP solutions were removed by pipetting, and excess media
allowed to evaporate in a laminar flow cabinet. Thereafter,
standardized (1 × 107 cells mL−1) S. mitis suspension in AS was
added to the wells. The bacteria were allowed to adhere for 4 h
at 37 °C. After incubation, non-adherent cells were removed by
rinsing the wells twice with PBS before adding TSB containing
10% (v/v) AlamarBlue® (Life Technologies Ltd, Paisley, UK).37
The plate was incubated for 2 h at 37 °C, after which the
AlamarBlue® suspension was transferred into a clean micro-
titre plate, and the absorbance measured at 570 and 600 nm
using a microplate reader (FluoStar Omega, BMG Labtech,
UK). A percentage reduction in biofilm viability was calculated
as described previously.38 The experiment was performed on
two diﬀerent occasions using six replicates.
Determining the eﬀect of (poly)phenols on maturation of
single-species S. mitis biofilms
In order to evaluate the inhibitory eﬀects of PPs on freshly
adhered sessile cells, a standardized inoculum suspension
(1 × 107 CFU mL−1) of S. mitis was prepared in artificial saliva
(AS). An aliquot (200 μL) was then transferred into each well of
a HA-coated 96-well plate. Following 4 h of adhesion, the
media containing non-adhered cells was removed by pipetting
and the biofilms washed twice with PBS. Subsequently, AS con-
taining PMIC concentrations of selected PPs were added into
each well, and further incubated for 20 h at 37 °C. Appropriate
positive and negative (growth and sterility) controls were also
included. Following incubation, biofilm containing wells were
washed with PBS and viability of the biofilms assessed using
AlamarBlue® as described in the previous section.37 The experi-
ment was performed on two independent time points using
six replicates.
Eﬀect of (poly)phenols on metabolic activity and ultra-
structure changes in a mature, multi-species, pathogenic
biofilm
The eﬀect of selected PPs on the metabolic activity of a mature
multi-species biofilm was assessed using an in vitro biofilm
model developed by our group.38 Biofilms were formed on pre-
sterilised, HA discs (Clarkson Chromatography Products Inc.,
Williamson, PA, USA). To produce multi-species biofilm,
500 μL of standardized (1 × 107 CFU mL−1) S. mitis (pioneer
species) inoculum in AS was added to 24-well plates containing
HA discs and incubated at 37 °C, in 5% CO2 for 24 h. Follow-
ing incubation, the supernatant was removed and fresh AS
containing standardized F. nucleatum added, which was
further incubated anaerobically for 24 h at 37 °C. The super-
natant was removed and standardised P. gingivalis and A. acti-
nomycetemcomitans added. The plates were incubated
anaerobically for a further four days with fresh AS replaced
daily. On the seventh day, the biofilms were washed twice with
PBS before addition of fresh AS containing PMIC concen-
tration of the selected PPs. After 24 h incubation, the meta-
bolic activity of the cells was assessed using the AlamarBlue®
assay, as described above.
To assess ultra-structural change of biofilms following PP
treatment, scanning electron microscopy (SEM) was performed
on PP-treated, mature, multispecies biofilms and untreated
controls. Briefly, cells were standardised as described above,
and grown directly onto Thermanox™ coverslips (Nunc, Ros-
kilde, Denmark) to allow biofilm formation. Following matu-
ration, biofilms were carefully washed with PBS and treated
with PMIC concentrations of the selected PPs for 24 h. Follow-
ing treatment, biofilms were again washed with PBS and then
fixed in 2% para-formaldehyde, 2% gluteraldehyde and 0.15 M
sodium cacodylate, and 0.15% w/v Alcian Blue, pH 7.4, and
prepared for SEM as previously described.39 The specimens
were sputter-coated with gold and viewed under a JEOL
JSM-6400 scanning electron microscope. Images were
assembled using Photoshop (Adobe, San Jose, CA, USA).
Statistical analysis
Data distribution and statistical analysis was performed using
GraphPad Prism (Version 5; LaJolla, CA, USA). Unpaired t-tests
were used to assess diﬀerences between two independent
samples. Statistical significance was achieved if p < 0.05.
Results
Eﬀect of (poly)phenols on planktonic growth of test strains
We first set out to screen a panel of PPs on our test organisms
to determine if any showed antimicrobial activity. An indicative
selection of 48 PPs from two major groups, flavonoids (n = 27)
and non-flavonoids (n = 21) were selected. Based on solubility,
a range of serial double dilutions of each PP was tested, and
the PMIC and PMBC determined (Table 1). All PPs tested dis-
played antimicrobial activity against one or more test strains,
except for kaempferol-3-glucuronide, epicatechin, malvin
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Table 1 Planktonic antimicrobial activity of test (poly)phenols acids against periodontal pathogens
Range testeda
S. mitis A. actinom. P. gingivalis F. nucleatum
MIC MBC MIC MBC MIC MBC MIC MBC
Hydroxybenzoic acids
Benzoic acid 4.88–2500 1250 >2500 625 1250 625 >2500 625 625
3-Hydroxybenzoic acid 4.88–2500 2500 2500 625 1250 1250 >2500 1250 >2500
4-Hydroxybenzoic acid 4.88–2500 1250 2500 625 1250 2500 >2500 1250 >2500
3,4-Dihydroxybenzoic acid 4.88–2500 1250 2500 312.5 312.5 1250 2500 1250 1250
Gallic acid 4.88–2500 312.5 1250 9.6 9.6 1250 2500 2500 2500
Hippuric acid 4.88–2500 2500 2500 1250 1250 1250 >2500 2500 >2500
Syringic acid 1.46–750 >750 >750 750 750 375 >750 750 1500
Vanillic acid 2.92–1500 750 >1500 325 650 1500 >1500 1500 1500
Hydroxycinnamic acids
Chlorogenic acid 4.88–2500 >2500 >2500 312.5 312.5 312.5 >2500 525 >2500
Coumaric acid 2.92–1500 1500 1500 375 375 750 >1500 750 1500
Ferulic acid 1.46–750 >750 >750 375 750 750 >750 375 >750
Caﬀeic acid 0.97–500 >500 >500 62.5 62.5 62.5 >500 62.5 500
Hydroxyphenylacetic acid
Phenylacetic acid 4.88–2500 1250 2500 625 1250 2500 2500 1250 >2500
3-Dihydroxyphenylacetic acid 4.88–2500 2500 2500 1250 1250 2500 2500 2500 >2500
3,4-Dihydroxyphenylacetic acid 4.88–2500 312.5 2500 4.88 4.88 2500 2500 2500 2500
3-Methoxy-4-hydroxyphenylacetic acid 4.88–2500 2500 2500 1250 1250 2500 2500 2500 >2500
Flavonols
Quercetin 0.97–500 250 >500 31.25 31.25 62.5 >500 500 >500
Quercetin 3-O-glucoside 0.488–250 >250 >250 325 325 125 >250 250 >250
Quercetin 3-O-glucuronide 0.488–250 >250 >250 >250 >250 >250 >250 250 >250
Kaempferol 3-O-rutinoside 0.24–125 >125 >125 >125 >125 125 >125 125 >125
Kaempferol 3-O-glucuronide 0.488–250 >250 >250 >250 >250 >250 >250 >250 >250
Kaempferol 7-O-neohesperidoside 0.24–125 >125 >125 >125 >125 125 >125 125 >125
Flavanols
Theaflavin extract 0.488–250 >250 >250 >250 >250 >250 >250 >250 >250
Procyanidin B2 0.488–250 >250 >250 >250 >250 >250 >250 >250 >250
Catechin 0.488–250 >250 >250 250 250 250 >250 >250 >250
Epicatechin 0.488–250 >250 >250 >250 >250 >250 >250 >250 >250
Epigallocatechin 0.488–250 250 >250 31.25 31.25 250 >250 125 >250
Epigallocatechin 3-O-gallate 4.88–2500 312.5 625 39.06 39.06 156.25 156.25 312.5 312.5
Epicatechin 3-O-gallate 0.488–250 >250 >250 250 250 125 250 >250 >250
Catechin 3-O-gallate 0.24–125 >250 >250 >250 >250 125 125 >250 >250
Flavanones
Naringenin 2.92–1500 162.5 325 162.5 162.5 46.87 375 162.5 325
Naringin 2.92–1500 >1500 >1500 >1500 >1500 750 1500 1500 >1500
Rutin hydrate 0.97–500 500 >500 250 >500 >500 >500 500 >500
Hesperitin 0.97–500 125 125 62.5 62.5 15.62 >500 125 125
Hesperidin 0.97–500 >500 >500 31.25 31.25 500 >500 >500 >500
Anthocyanins
Malvidin 0.488–250 >250 >250 62.5 62.5 31.25 62.5 125 >250
Malvin 0.488–250 >250 >250 >250 >250 >250 >250 >250 >250
Malvidin 3-O-galactoside 0.488–250 >250 >250 125 125 125 >250 >250 >250
Pelargonidin 0.97–500 >500 >500 62.5 62.5 62.5 >500 >500 >500
Oenin 0.488–250 >250 >250 125 125 >250 >250 >250 >250
Pelargonin 0.488–250 >250 >250 >250 >250 125 >250 >250 >250
Flavones
Apigenin 0.488–250 >250 >250 >250 >250 15.62 >250 125 >250
Isoflavonoids
Daidzein 0.488–250 >250 >250 >250 >250 500 >250 500 >250
Phenolics
Pyrocatechol 4.88–2500 312.5 312.5 4.88 4.88 312.5 312.5 312.5 312.5
Resorcinol 4.88–2500 2500 2500 1250 1250 1250 2500 2500 2500
Phloroglucinol 2.92–1500 1500 >1500 137.50 137.50 375 750 750 750
Pyrogallol 4.88–2500 9.76 19.5 2.4 2.4 312.5 312.5 2500 2500
Curcumin 0.390–200 62.5 >200 15.62 15.62 7.81 15.62 31.25 62.5
a Range of test concentration, All MIC values are in μg mL−1. A actinom. = A. actinomycetemcomitans.
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(highest concentration tested: 250 μg ml−1), theaflavin and pro-
cyanidin B2 (highest concentration tested: 125 μg ml−1).
Among all the PPs tested, curcumin was the most potent
inhibitor of planktonic growth, with an MIC range of
7.81–62.5 μg mL−1, against all test strains. The highest activity
was shown against P. gingivalis (PMIC = 7.81 μg mL−1) and
A. actinomycetemcomitans (PMIC = 15.62 μg mL−1). Curcumin
was followed by pyrogallol (very wide PMIC range; 2.4–2500 μg
mL−1), pyrocatechol (PMIC range 4.88–312.5 μg mL−1) and
quercetin (PMIC range 31.25–500 μg mL−1). Apigenin and
daidzein were eﬀective only against anaerobic bacteria (PMIC
range 15.6–125 μg ml−1 and 500 μg ml−1, respectively) at the
concentrations tested.
The PMBC for the majority of PPs was either the same or
2×PMIC. Wide variations in the susceptibility (mean MIC ±
SD) to PPs were observed among the test strains (Table 2 and
Fig. 1). A. actinomycetemcomitans showed highest susceptibility
(p < 0.05) to test PPs, with a mean PMIC of 341 ± 393 μg mL−1
compared with S. mitis (1027 ± 916 μg mL−1, p < 0.001), P. gin-
givalis (691 ± 811 μg mL−1, p < 0.05) and F. nucleatum (941 ±
895 μg mL−1, p < 0.001) (Table 2). The order of PPs suscepti-
bility of the test strain was A. actinomycetemcomitans > P. gingi-
valis > F. nucleatum > S. mitis.
Relationship between (poly)phenols structure and
antibacterial activity
In order to assess structure–function relationship, the organ-
ism most susceptible to a broad range of PPs (A. actinomyce-
temcomitans) was studied.
Antimicrobial activity increased considerably (lower MICs)
with increasing number of OH groups attached to the benzene
ring (Table 3). The antibacterial activity was also dependent on
the location of the OH group. This was reflected in the higher
antibacterial potential (lower PMICs) of pyrogallol (1,2,3-tri-
hydroxybenzene; PMIC 2.4 μg mL−1) and pyrocatechol (1,2-di-
hydroxybenzene; PMIC 4.8 μg mL−1), having the same structure
as phloroglucinol (1,3,5-trihydroxybenzene; PMIC 137.5 μg
mL−1) and resorcinol (1,3-dihydroxybenzene; PMIC 1250 μg
mL−1) respectively, but diﬀerent hydroxylation pattern and
higher PMIC values. A similar trend was observed for other
PPs (Table 3). The presence of pyrogallol (3,4,5-trihydroxybenz-
oyl) group in the chemical structure of PPs also increased the
antibacterial activity. For example, flavan-3-ols containing a
pyrogallol (1,2,3-trihydroxybenzene) moiety in their structure
(epigallocatechin, epigallocatechin 3-O-gallate, epicatechin
3-O-gallate) had lower PMICs (31.2, 39.0, 250 μg mL−1 respecti-
vely) and higher antibacterial activity than epicatechin and
procyanidin B2 containing catechol group (1,2-dihydroxy-
benzene) which possessed higher PMICs (>250 μg mL−1).
Aglycones (PP with no sugar group attached) were stronger
(lower MICs) at inhibiting the growth of A. actinomycetemcomi-
tans than corresponding glycosides (PPs with attached glucose
moiety). An example is quercetin, an aglycone, which had a
much lower MIC (31.25 μg mL−1) than its glycoside, quercetin-
3-O-glucoside (MIC = 325 μg mL−1). The same was true for
other aglycones and corresponding glycosides (Table 4).
The PMIC data was thoroughly reviewed and only a subset
of the most eﬀective PPs (those with PMIC values of <100 μg
mL−1 against one or more of the test strains) were carried
forward for subsequent assays. Selected PPs (n = 10) included
curcumin, quercetin, EGC, EGCG, pyrogallol, gallic acid,
3,4-dihydroxyphenyl acetic acid, naringenin, hesperetin and
pyrocatechol.
Eﬀect of selected (poly)phenols on single-species S. mitis
biofilms
Given that S. mitis is one of the key pioneer species in dental
plaque biofilm and is required for subsequent complex
Fig. 1 Scatter dot plot with individual MICs of individual eﬀective PPs in
each subgroup (ﬂavonoids n = 27, non-ﬂavonoids n = 21). Line represent
mean of all PP against the test strain. Aa = A. actinomycetemcomitans,
Sm = S. mitis, Pg = P. gingivalis, Fn = F. nucleatum.
Table 2 Comparison of mean minimum inhibitory concentration (PMIC) of (poly)phenols for diﬀerent test strainsa
Parameter
Test strain
S. mitis A. actinomycetemcomitans P. gingivalis F. nucleatum
No of eﬀective PPs 23/48 35/48 40/48 35/48
Range 9.76–2500 2.4–1250 7.81–2500 31.25–2500
MIC 1027 ± 916*** 341 ± 393 691 ± 811* 941 ± 895***
a All MIC Values are given as Mean ± S.D. (μg mL−1). Significant diﬀerence between MIC of A. actinomycetemcomitans compared with other test
strains. *p < 0.05, ***p < 0.001 (T test).
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biofilm formation and maturation, we wanted to determine if
these PPs had the capacity to inhibit diﬀerent stages of S. mitis
biofilm.
The potential for PPs to adsorb onto HA, a key constituent
of tooth enamel was tested. After 1 h incubation, the amount
of PP adsorbed ranged from 1–66.5 μg g−1 HA. Compared with
the control, a significant adsorption was observed for curcumin
(p < 0.001), EGC (p < 0.05), EGCG (p < 0.001), and pyrogallol
(p < 0.01) (Fig. 2). Other PPs (gallic acid, 3,4-dihydroxyphenyl
acetic acid, naringenin, quercetin, hesperetin and pyrocatechol)
did not show any significant adsorption onto HA.
Adsorption of PP onto substrate (HA coated, 96-well
plate) with the ten selected PPs (at PMIC) resulted in diﬀeren-
tial suppression of S. mitis biofilms (Fig. 3). Biofilm suppres-
sion ranged from 1 to 12% of the untreated control, with
significant (p < 0.05) inhibitory activity shown by quercetin
only (12%).
The ten selected PPs were also tested at their PMIC against
maturation of S. mitis biofilms. Decreased viability (3–10%) in
biofilms was observed following treatment with gallic acid
(p < 0.01), curcumin (p < 0.001), hesperetin (p < 0.001), and
pyrocatechol (p < 0.001) compared with untreated controls
Table 3 Eﬀect of hydroxylation of non-ﬂavonoid phenolic compounds on planktonic growth of A. actinomycetemcomitans
Basic structure of non-flavonoids
PP Compound (chemical name) Common name Hydroxylation pattern Substitutions R MIC (μg mL−1)
1,2-Dihydroxybenzene Pyrocatechol 1,2 OH 4.88
1,3-Dihydroxybenzene Resorcinol 1,3 OH 1250
1,2,3-Trihydroxybenzene Pyrogallol 1,2,3 OH 2.4
1,3,5-Trihydroxybenzene Phloroglucinol 1,3,5 OH 137.50
4-Hydroxybenzoic acid 4 COOH 625
3,4-Dihydroxybenzoic acid Protocatechuic acid 3,4 COOH 312.5
3,4,5-Trihydroxybenzoic acid Gallic acid 3,4,5 COOH 9.6
3-Hydroxyphenylacetic acid 3 CH3COOH 1250
3,4-Dihydroxyphenylacetic acid Homoprotocatechuic acid 3,4 CH3COOH 4.88
4-Hydroxycinnamic acid Coumaric acid 4 CH–CH–COOH 375
3,4-Dihydroxy-cinnamic acid Caﬀeic acid 3,4 CH–CH–COOH 62.5
Table 4 Eﬀect of hydroxylation of ﬂavonoid glycosides and corresponding aglycones on growth of A. actinomycetemcomitans
Basic structure of flavonoids
PP compound (chemical name) Common name Hydroxylation pattern Substitutions R MIC (μg mL−1)
Quercetin 3-O-glucoside Isoquercetin 5,7,3,4 3-O-Glucoside 325
Quercetin-3-O-rutinoside Rutin 5,7,4′,5′ 3-O-Rutinoside 250
3,5,7,3′,4′-Penta-hydroxyXavone Quercetin 3,5,7,3′,4′ Nil 31.25
Naringenin 7-O-neohesperidoside Naringin 5,7,4′ 7-Rhamnoglucoside >1500
5,7,4′-Trihydroxyflavanone Naringenin 5,7,4′ Nil 162.5
Malvidin 3,5-O-diglucoside Malvin 7,4′ 3,5-Diglucoside >250
Malvidin 3-O-glucoside Oenin 5,7,4′ 3-O-Glucoside 125
Malvidin 3-O-galactoside 5,7,4′ 3-O-Galactocoside 125
3,5,7,4′-Tetrahydroxy-3′,5′-dimethoxyflavylium Malvidin 3,5,7,4′ Nil 62.5
Pelargonidin 3,5-O-diglucoside Pelargonin 7,4′ 3,5-Diglucoside >250
3,5,7,4′-Tetrahydroxyflavylium Pelargonidin 3,5,7,4′ Nil 62.5
Hesperetin 7-O-rutinoside Hesperidin 5,3′ 7-O-Rutinoside 62.5
5,7,3′-Trihydroxy-4′-methoxyflavanone Hesperetin 5,7,3′ Nil 31.25
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(Fig. 4). Other PPs (3,4-dihydroxyphenylacetic acid, quercetin,
EGC, EGCG and pyrogallol) showed no significant eﬀect on
biofilm maturation.
A summary of the levels at which the ten selected PPs were
eﬀective in relation to adsorption to substrate and inhibition
of biofilm formation or maturation is given in Table 5. It is
interesting to note that none of the ten PPs were significantly
involved in all three steps (adsorption, inhibition of formation
or maturation).
Bactericidal eﬀect of curcumin and quercetin on mature,
multi-species, pathogenic biofilm and ultrastructure changes
The metabolic activity of complex 4-species biofilms was sig-
nificantly decreased (p < 0.05) in curcumin-treated biofilms
Fig. 2 Adsorption of polyphenols onto hydroxyapatite. Standardized
PPs solution (50 μg mL−1) was incubated in the presence and absence of
200 mg HA powder for one hour followed by centrifugation at 5000g
for 5 minutes. Total PPs concentration of the supernatants was deter-
mined using the Folin–Ciocalteau method. The assay was performed on
two independent occasions, each with triplicate. Unpaired t-test was
used to compare the diﬀerence between sample and control. 3,4-diOH
PAA = 3,4-dihydroxyphenylacetic acid, EGC = epigallocatechin, EGCG =
epigallocatechin 3-O-gallate. Error bars represent SEM (*p < 0.05,
**p < 0.01, ***p < 0.001).
Fig. 3 Eﬀect of selected (poly)phenols adsorption on formation of S.
mitis bioﬁlm. Selected PPs (PMIC) were allowed to coat surface of the
substrate (HA coated, 96-well plates) overnight. The solution was
removed by pipetting and the substrate is air-dried before adding stan-
dardized (1 × 107 CFU mL−1) inoculum of S. mitis prepared in artiﬁcial
saliva. After 4 h incubation, media was removed and the well were
gently washed with PBS. Bioﬁlm was then quantiﬁed by adding Alamar-
Blue® for 2 h and measuring absorbance at 570 and 600 nm using a
microplate reader. The assay was performed on two independent
occasions using six replicates. Unpaired t-test was used to compare the
diﬀerence between treatments and controls. 3,4-diOH PAA = 3,4-dihy-
droxyphenylacetic acid, EGC = epigallocatechin, EGCG = epigallocate-
chin 3-O-gallate. * (p < 0.05). Error bars represent SEM.
Fig. 4 Eﬀect of selected (poly)phenols on maturation of S. mitis
bioﬁlm. Standardized inoculum suspension (1 × 107 CFU mL−1) of
S. mitis in artiﬁcial saliva and supplemented TSB was added to HA
coated, 96-well plates and incubated for 4 h to allow adhesion and
bioﬁlm formation by S. mitis. After incubation, bioﬁlm were washed
twice with PBS before treating with PMIC of selected PPs for 20 h. Both
positive and negative control were included. After 20 h incubation,
media was removed and the well were gently washed with PBS. Bioﬁlm
biomass was then quantiﬁed by adding AlamarBlue® for 2 h and
measuring absorbance at 570 and 600 nm using a microplate reader.
The assay was performed on two independent occasions using six repli-
cates. 3,4-diOH PAA = 3,4-dihydroxyphenylacetic acid, EGC = epigallo-
catechin, EGCG = epigallocatechin 3-O-gallate. Unpaired t-test was
used to compare the diﬀerence between treatment and untreated con-
trols. Error bars represent SEM, **p < 0.01, ***p < 0.001.
Table 5 Summary of the eﬀect of selected PPs adsorption and eﬀect
on key phases of S. mitis bioﬁlm formation and maturationa
PP Adsorption Biofilm formation Biofilm maturation
Gallic acid ✓
3,4-DiOH PAA
Quercetin
Curcumin ✓ ✓
Hesperitin ✓
Naringenin
EGC ✓ ✓
EGCG ✓
Pyrogallol ✓
Pyrocatechol ✓
a 3,4-diOH PAA = 3,4-dihydroxyphenylacetic acid, EGC =
epigallocatechin, EGCG = epigallocatechin 3-O-gallate.
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compared with controls, but not quercetin-treated biofilms
(Fig. 5A). SEM analysis of mature, multi-species biofilms
treated with curcumin and quercetin are shown in Fig. 5B–D.
Untreated biofilms covered the entire coverslip with all strains
(S. mitis, A. actinomycetemcomitans, P. gingivalis & F. nucleatum)
clearly visible and embedded in extracellular matrix (Fig. 5B),
whereas curcumin-treated biofilms predominantly contain
S. mitis (Fig. 5C) with no extracellular matrix visible. Biofilms
treated with quercetin showed loss of biomass compared with
untreated controls, and lack of F. nucleatum and extracellular
matrix (Fig. 5D). Bacteria, especially P. gingivalis, appeared to
swell and rupture (Fig. 5D, inset).
Discussion
Global prevalence of PD, coupled with partial eﬀectiveness of
current treatments (due to development of antibiotic resist-
ance), poses a significant challenge to scientists and oral
health professionals across the world.40,41 There is, therefore,
an opportunity for identification and testing of natural,
alternative, therapeutic agents for prevention and/or manage-
ment of the disease. Here, we have reported the antibacterial
potential of PPs against key periodontal pathogens, which may
be helpful in the prevention and possibly management of PD.
An important consideration for cell-based assays involving
PPs is their solubility. Many PPs are water insoluble and sol-
vents such as dimethyl sulfoxide (DMSO), methanol or ethanol
are often used. However, the antibacterial activity of these sol-
vents can often interfere with the interpretation of the data.42
Keeping these limitations in mind, we first confirmed that
DMSO in the concentration of 2.5% (v/v) was the most suitable
solvent, having no discernible eﬀect on the growth of the test
strain (data not shown). Previously reported PMICs of PPs
against P. gingivalis were noticeably diﬀerent from our data
(Table 1), i.e. gallic acid (MIC = 1 mg mL−1), quercetin (250 mg
mL−1), naringin (250 mg mL−1), EGCG (500 μg mL−1) and EGC
(1000 μg mL−1).21,23,26–28 This is, most probably, due to vari-
ations in the methods used for susceptibility testing, some
authors have used the agar dilution method, diﬀerent test
strains, and sources of PP (commercial or natural).
A species-dependent susceptibility of periodontal patho-
gens to PPs was observed, where the PMIC for Gram negative
test strains (A. actinomycetemcomitans, P. gingivalis & F. nuclea-
Fig. 5 (A–D) Eﬀect of quercetin and curcumin on metabolic activity and ultra-structure changes in mature, multi-species bioﬁlms. Multi-species (S.
mitis, A. actinomycetemcomitans, P. gingivalis & F. nucleatum) bioﬁlms were grown in 24 well plates containing HA discs or Thermanox™ coverslips
in artiﬁcial saliva. Bioﬁlms were allowed to mature for 7 days followed by treatment with PMIC concentration of curcumin and quercetin for
24 hours (A) After treatment, bioﬁlm biomass was quantiﬁed adding AlamarBlue® and measuring absorbance at 570 and 600 nm using a microplate
reader. Unpaired t-test was used to compare the diﬀerence between treatment and untreated controls. Error bars represent SEM, *p < 0.05 (B–D)
Bioﬁlms grown on coverslips were processed, viewed under scanning electron microscope and images assembled using Adobe Photoshop. B =
normal bioﬁlm, C = curcumin-treated bioﬁlm, D = quercetin-treated bioﬁlm. PG = P. gingivalis, FN = F. nucleatum, AA = A. actinomycetemcomitans,
SM = S. mitis.
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tum) was lower than for the Gram positive test strain S. mitis
(Table 2). Similar results have been obtained by Bakri and
Douglas43 where Gram negative oral bacteria (A. actinomycetem-
comitans, P. gingivalis & F. nucleatum) were more susceptible to
the action of allicin (present in garlic extract) than strepto-
cocci. This diﬀerential activity of PPs was further reflected in
the time kill curves performed on Gram positive S. mutans and
Gram negative P. gingivalis.43 Among Gram-negative bacterial
strains tested in our study, F. nucleatum was the least suscep-
tible to the action of PPs and in some cases the PMIC value
was approaching that for the Gram-positive strain (S. mitis).
Interestingly, in addition to an outer membrane, F. nucleatum
has a large periplasmic space surrounded by peptidoglycan
layers, in-between the outer and inner cytoplasmic mem-
branes.44 Therefore, it is reasonable to speculate that
decreased sensitivity of the bacterium could be partly due to
its membrane structure, which could hamper access of PPs to
the target enzymes in cytoplasmic and perioplasmic space.
Similarly, the diminished sensitivity of S. mitis may be
explained by the presence of a thick peptidoglycan layer in the
cell wall of Gram-positive bacteria.45 The diﬀerence between
PMIC and PMBC values reflect that the PPs tested in this study
were bactericidal in their activity against the test strains. These
result were in agreement with a recently published study.46
Our study also reported for the first time the relationship
between the chemical structure of PPs and antibacterial
activity against A. actinomycetemcomitans, the most susceptible
of the test strains. We have shown that increased hydroxylation
of the benzene ring in phenolic acids and benzene alcohols is
associated with increases antibacterial activity. The opposite
association was reported previously for E. coli.29 This diﬀer-
ence could be due to the use of diﬀerent antimicrobial suscep-
tibility assay, in addition to test strains (E. coli) and growth
conditions. We showed that PPs containing a 3,4,5-trihydroxy-
phenyl (pyrogallol) group in their chemical structure were
more potent inhibitors (possessing lower PMICs) of the
growth of A. actinomycetemcomitans than PPs containing 1,2
dihydroxyphenyl (pyrocatechol) groups. These findings are in
agreement with Taguri et al.47,48 who report an increased anti-
bacterial potential of PPs containing a pyrogallol moiety
against a number of food-borne pathogenic bacteria (n = 96)
including both Gram positive and Gram negative strains. We
also observed a stronger antibacterial activity of aglycones than
their corresponding PP glycosides. PPs present in foods are
mainly found in the glycosylated form however, reports indi-
cate that PP glycosides can be hydrolysed into aglycones by
salivary enzymes and the oral microflora.49,50 This further
raises the possibility of increased antimicrobial activity of PPs
in the oral cavity following dietary consumption that can also
contribute to the prevention of oral infectious diseases includ-
ing periodontitis.
The primary aetiological factor in PD is biofilm formation
and its dynamic complexity. Theoretically, inhibition of the
early steps in this process can result in the prevention of peri-
odontal diseases, as has been the focus in developing vaccines
against the pioneer species.51 An important property of PPs is
their ability to adhere to oral hard and soft tissues, microbes
and salivary proteins.52,53 Our study has confirmed that PPs,
especially curcumin, possess high adsorptive aﬃnity for HA
that can be employed in increasing the local (oral) availability
of PPs. This can further help in preventing and inhibiting
biofilm formation on tooth surface, either through physical
inhibition54 or high antimicrobial properties observed in this
study and elsewhere.55 Both curcumin and quercetin can also
aﬀect the metabolic activity and architecture of mature, multi-
species, pathogenic biofilm. The activity of both curcumin and
quercetin appeared to be selective based on imaging of the
biofilms; depleting only specific pathogens in mature biofilms,
leaving a biofilm composed mainly S. mitis. This finding
is interesting because S. mitis is a part of the normal oral
flora, and biofilms containing only streptococci are inert and
pose no threat per se to oral health. Also, swelling and
rupture of P. gingivalis cells following treatment with quercetin
may be a mechanism for the observed killing activity by
quercetin.
Along with key strengths (the large screening, use of pub-
lished guidelines, use of planktonic and biofilm assays, and
single and multispecies models), this study presents some
limitations. Adsorption of PPs onto HA-coated 96-well plates
or commercial HA discs might be diﬀerent than adsorption
onto HA powder; due to diﬀerences in the available surface
area and details (HA discs are more polished). Quantification
of PPs adsorption onto HA discs using an ellipsometer would
be helpful in this regards, and further studies combining HA
with simulated salivary pellicle as a more complex surface are
warranted. In addition, the antimicrobial susceptibilities and
relationship between PPs structure and antimicrobial activity
need to be further evaluated by using other species and clini-
cal strains. Multispecies biofilm models have been extensively
used in our group;38 their construction however can diﬀer, and
ours is completely diﬀerent (both in term of the number of
bacterial species and the sequence of addition of bacterial
strains to produce a biofilm) from other recent work56 report-
ing death of S. mitis in biofilm following addition of
P. gingivalis.
Collectively our observations provide evidence that the PPs
tested in this study may be important in preventing oral
microbial diseases and maintaining oral health. Potential
routes for exploitation of PPs beneficial activities (antibacterial
potential) include dietary intervention and pharmaceutical
preparations. For the most active PPs, the PMICs were less
than 100 μg mL−1 which can be achieved through diet as they
are present in commonly consumed foods. For example, tea
(green, black, oolong), turmeric and onions are rich sources of
curcumin, EGCG and quercetin.57 It is estimated that one cup
of tea (240 mL) contain 240 mg of EGCG.58 Moreover, the esti-
mated daily intake of turmeric in Nepal and India is approxi-
mately 1500–2500 mg per day corresponding to 50–100 mg of
curcumin.59 In the Dutch population, the estimated flavonoid
intake, of which 70% is quercetin, is about 34 mg per day.60
Oral availability of PP can be potentiated by their ability to
adsorb onto the tooth surface.
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Where adequate intake cannot be achieved by diet alone,
there are opportunities to use PPs for pharmaceutical develop-
ment of oral healthcare products. Indeed, PPs containing
toothpaste and dental gel are available in the market (AO Pro-
Toothpaste, AO ProVantage dental gel and Antioxidant Oral
Care System marketed by PERIOSCIENCES©) containing natural
(poly)phenols (phloretin & ferrulic acid) with no clinical data so
far supporting a PP-specific eﬀect on oral health. A key con-
sideration for oral healthcare is the potential for tooth staining,
which was demonstrated for tea polyphenolic extracts.33,61 Prepa-
ration of synthetic analogues with superior or optimal thera-
peutic properties without staining risk may be more suitable.62
We have demonstrated the antibacterial potential of PPS in vitro,
further cellular and in vivo studies are required for successful use
of PPs in the prevention and treatment of periodontal diseases.
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